Furthermore, co‐inhibition of FAK and Gli1 efficiently suppressed Ki67, CD31, and LYVE1 levels in ESCC tumors than each agent alone (Figure 6B–D). Here, LYVE1 is linked to esophageal squamous cell carcinoma.